“No matter the creature, creed, or character... It is universal. All beings feel it. All succumb in one way or another. Some hide from it. Few try to fight it. Others outright deny it. All of it... futile. Regardless of one’s predilection of the subject one thing is certain: Fear has a rather strange and peculiar way of bringing forth the true face underneath the mask we wear. In all my time... in all my studies... A single undeniable truth exist: Fear is a key. And in the matters of the mind... I am the locksmith. When all is said and done, a new mythology will reign within an age of logic and reason long lost to the current Remnant. But only the truly keen will see... that I am not the only thing you should fear.“
“The ways of the world are frail and obsolete.
A new understanding lies beyond the burning horizon.
Remnant as a society cannot get there from here.
Not now. Not like this. But there are those... who are willing.”
A catalyst must be introduced.
A poison cure. An venom antidote. A push off the bleeding edge.
Experiment B14-D5T was designed to enhance a Hunter/Huntress' Aura and Semblance through intravenous injections. Through repeated exposure, Subject [REDACTED] has reacted positively to B14-D5T. [REDACTED] has given Subject [REDACTED] permission to self-administer B14-D5T.
First exposure began with 1mg B14-D5T, injected by [REDACTED]. Subject [REDACTED] was restrained on experiment table. Subject [REDACTED] appeared to have an extreme adverse reaction, with symptoms including (but not limited to) nausea, hallucinations, sweating and inability to control Semblance. Subject [REDACTED] flatlined and was resuscitated. Transferred to recovery station and monitored for seven days.
Second exposure began with 2mg B14-D5T, injected by [REDACTED]. Subject [REDACTED] was restrained on experiment table. Subject [REDACTED] appeared to have an extreme adverse reaction, with symptoms including (but not limited to) nausea, hallucinations, sweating and seizures. Subject [REDACTED] flatlined and was resuscitated. Transferred to recovery station and monitored for seven days.
Third exposure began with 5mg B14-D5T, injected by [REDACTED]. Subject [REDACTED] was restrained on experiment table. Subject [REDACTED] appeared to have an adverse reaction, with symptoms including (but not limited to) nausea, hallucinations, sweating, seizures and aggressive behavior. Transferred to recovery station and monitored for five days.
Fourth exposure began with 5mg B14-D5T, injected by [REDACTED]. Subject [REDACTED] was restrained on experiment table. Subject [REDACTED] appeared to have an adverse reaction, with symptoms including (but not limited to) sweating, seizures and aggressive behavior. Transferred to recovery station and monitored for three days.
Fifth exposure began with 10mg B14-D5T, injected by [REDACTED]. Subject [REDACTED] appeared to have an adverse reaction, with sweating and nausea. Transferred to recovery station and monitored for two days.
Sixth exposure began with 10mg B14-D5T, injected with supervision by Subject [REDACTED]. Subject [REDACTED] appeared to have an adverse reaction, with nausea and staining of skin at injection point. Transferred to recovery station and monitored for 24 hours.
Seventh exposure began with 15mg B14-D5T, injected with supervision by Subject [REDACTED]. Subject [REDACTED] appeared to have an adverse reaction, with nausea and staining of skin at injection point. Transferred to recovery station and monitored for 24 hours.
Eighth exposure began with 25mg B14-D5T, injected with supervision by Subject [REDACTED]. Subject [REDACTED] appeared to have no adverse reaction, with staining of skin and veins at injection point. Transferred to recovery station and monitored for 24 hours.
Ninth exposure began with 40mg B14-D5T, injected by Subject [REDACTED]. Subject [REDACTED] appeared to have no adverse reaction, with staining of skin and veins at injection point and lower left forearm. Transferred to recovery station and monitored for 24 hours.
Tenth exposure began with 2g B14-D5T, injected by Subject [REDACTED]. Subject [REDACTED] appeared to have an adverse reaction, with symptoms including (but not limited to) nausea, sweating, seizures and hallucinations. Subject [REDACTED] flatlined and resuscitated. Transferred to recovery station and monitored for three days.
Eleventh exposure began with 25mg B14-D5T, injected with supervision by Subject [REDACTED]. Subject [REDACTED] appeared to have no adverse reaction, with staining of skin and veins at injection point and lower left forearm. Transferred to recovery station and monitored for 24 hours.
Twelfth exposure began with 40mg B14-D5T, injected with supervision by Subject [REDACTED]. Subject [REDACTED] appeared to have no adverse reaction; staining of skin, veins and fingers at injection point and lower left forearm and hand. Transferred to recovery station and monitored for 24 hours.
And you cant stop now, row by row, almost out.
Covered in black and gold. No one cares, no one knows.
My gift to the world outside. It's okay, I'm alright
Now open your empty hands
Here comes the fun, here comes the end...
There’s a G̭͎͖̞̥̦̹̥̗̲̦͇̾̒̏̒̒͛͛ͩ̐ͨ̐ͪ̅͂̇̚L̫̹̜͙̪̪̠̣̰̟̗̪͉̥̅͑̋ͩ̽̓̚I̼̪̤͙̫̗̟͑ͪ̈́͆̍̌T͖̖̗̘̪͍̭̻̖̬͍̻͓͈͖̺̭ͧ̌̂ͯ̊̐̋̏̾̓͊̽ͭ̈ͦͮ͒ͅC͓̹̞͉͎̖̝̤̐̊͑ͫͭ̀͑̏͛H͖͉͉̺͇͙͉̭ͮ̄ͩͧ̑̅ͯ͒́̈ͣ̌̎ in the system…
